Company intelligence / Profile preview

OG Corporation

Osaka, Osaka Prefecture, Japanogcorp.co.jp ↗

Ownership: Private
Development stage: Other

Overview

OG Corporation is a Japanese trading company with a significant pharmaceutical division specializing in the offshore OEM business for active pharmaceutical ingredient (API) discovery/importation, formulation, final packaging of generics, as well as comprehensive analytical testing. The company leverages its expertise and overseas network—mainly in Asia—to support the global pharmaceutical industry with high-quality products and technical solutions[2].

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Not explicitly listed. Likely partners include Asian API manufacturers/generic pharma companies due to their OEM/offshore model[2].

Beyond the preview

Go deeper on OG Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OG Corporation.

Explore the full profile